Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2026-03-14 @ 5:47 AM
Study NCT ID:
NCT03303469
Status:
TERMINATED
Last Update Posted:
2021-02-21
First Post:
2017-09-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging
Sponsor:
University of Alabama at Birmingham
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
F170519002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None